Sherrie L Perkins

The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL

Lauren Harrison, Changhong Yin, S. Perkins, 2017, Oncotarget.

Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals.

Chung-Che Chang, Brent Logan, Christopher Schultz, 2003, Archives of pathology & laboratory medicine.

Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma

Chung-Che Chang, Brent Logan, Andre Kajdacsy-Balla, 2004, The American journal of surgical pathology.

Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.

Monica E de Baca, Joseph D Khoury, Carol Colasacco, 2016, Archives of pathology & laboratory medicine.

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

Zhaosheng Lin, Kojo S J Elenitoba-Johnson, R. T. Abbott, 2003, Proceedings of the National Academy of Sciences of the United States of America.